|Videos|May 18, 2023
Updates in the Treatment of Advanced/Recurrent Endometrial Cancer: Data from the RUBY Trial
Dr Robert Coleman details data from the RUBY trial investing the role of checkpoint inhibitor dostarlimab in combination with chemotherapy for the treatment of advanced/recurrent endometrial cancer.
Advertisement
Episodes in this series
Advertisement
Related to this article
Beth Erickson, MD, FACR, FASTRO, FABS, discussed pioneering MRI-guided brachytherapy at MCW and her priorities as incoming ASTRO president-elect.
Advertisement
Advertisement
Trending on CancerNetwork
1
Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs
2
Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer
3
CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma
4
Using Intrathecal Dendritic Cells for Leptomeningeal Disease From Breast Cancer
5